Zobrazeno 1 - 10
of 97
pro vyhledávání: '"F. Elkik"'
Publikováno v:
Therapie. 52(6)
The aim of the present study was to investigate the incidence of adverse effects and the prognostic value of various risk factors in a large population of unselected hypertensive patients treated with the ACE inhibitor trandolapril. Among the 30 072
Publikováno v:
Therapie. 52(3)
In this double blind randomized study, blood pressure lowering effects and duration of action of two angiotensin converting enzyme (ACE) inhibitors were compared using home self blood pressure measurement (SBPM). After a two-week placebo run-in perio
Publikováno v:
American journal of hypertension. 9(7)
The SMART study (Self-Measurement for the Assessment of the Response to Trandolapril) was performed in general practice and enrolled 1710 patients in order to assess on a large scale the feasibility and informative value of self-measurement of blood
Publikováno v:
Journal of human hypertension. 10(6)
The SMART study (Self Measurement for the Assessment of the Response to Trandolapril) was a large scale trial conducted by general practitioners in order to assess the informative value of home self-measured blood pressure (BP) for the evaluation of
Autor:
J M, Mallion, C, Dutrey-Dupagne, L, Vaur, N, Genes, M, Renault, F, Elkik, P, Baguet, S, Boutelant
Publikováno v:
Journal of hypertension. 14(1)
This study was designed to assess the compliance of hypertensive patients with a once-daily regimen of the angiotensin converting enzyme (ACE) inhibitor trandolapril and to evaluate the antihypertensive efficacy of the drug in relation to the time in
Autor:
J M, Mallion, C, Dutrey-Dupagne, L, Vaur, N, Genes, M, Renault, P, Baguet, S, Boutelant, F, Elkik
Publikováno v:
Annales de cardiologie et d'angeiologie. 44(10)
The objective of the MACH1 study (MEMS for the Assessment of Compliance of Hypertensives) was to evaluate the real behaviour of patients in relation to antihypertensive treatment administered as a single daily dose. After a 2-week period during which
Publikováno v:
European Heart Journal. 6:525-531
Eleven patients, with recurrent paroxysmal supraventricular tachycardias (PSVT) underwent programmed electrical stimulation of the heart to evaluate the efficacy of intravenous (i.v.) and oral tiapamil in these arrhythmias. The tachycardia circuit wa
Autor:
P. Corvol, F. Elkik, P.N. Guyenne, Anne Gompel, Pierre Mauvais-Jarvis, C. Mercier-Bodard, Frédérique Kuttenn
Publikováno v:
American Journal of Obstetrics and Gynecology. 143:888-892
Percutaneous administration of estradiol (E2) is a new substitutive treatment for postmenopausal women. In order to compare hepatic action of percutaneous E2 with that of conjugated estrogens, 18 postmenopausal women were allocated at random to recei
Autor:
G. Goursot, B. Carcone, F. Elkik, J. Marty, Jean-Marie Desmonts, J.L. Cazor, J.M. Fargnoli, J.P. Caramella
Publikováno v:
Annales Françaises d'Anesthésie et de Réanimation. 7:245-250
A controlled double-blind trial was carried out to assess the efficacy and safety of a continuous intravenous infusion of diltiazem in preventing perioperative myocardial ischaemia in patients with coronary artery disease. Sixty-six patients undergoi
Publikováno v:
Fundamental & Clinical Pharmacology. 1:459-470
Summary— The dose-response for the new cardiotonic agent RO 13–6438 was studied in 6 patients with grade III or IV congestive heart failure. Oral doses of 10, 20, or 30 mg of RO 13–6438 were administered on 3 consecutive days in accordance with